My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Adani Ports gains after RBI hikes FPIs investment limit
Oct 03,2016

The Reserve Bank of India (RBI) made the announcement after market hours on Friday, 30 September 2016.

Meanwhile, the BSE Sensex was up 278.94 points, or 1%, to 28,144.90.

On BSE, so far 2.72 lakh shares were traded in the counter, compared with average daily volume of 4.89 lakh shares in the past one quarter. The stock hit a high of Rs 280 and a low of Rs 259.95 so far during the day. The stock hit a 52-week high of Rs 330.75 on 15 October 2015. The stock hit a 52-week low of Rs 169.65 on 12 February 2016. The stock had outperformed the market over the past 30 days till 30 September 2016, sliding 0.85% compared with 1.96% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 25.52% as against Sensexs 2.66% rise.

The large-cap company has equity capital of Rs 414.19 crore. Face value per share is Rs 2.

RBI notified that foreign institutional investors (FIIs)/registered foreign portfolios investors (RFPIs) can under the portfolio investment scheme (PIS) now invest upto 49% of the paid up capital of Adani Ports and Special Economic Zone (APSEZ). The purchases could be made through primary market and stock exchanges. RBI stated that the companys board of directors has passed a resolution and its shareholders have passed a special resolution agreeing for enhancing the limit for the purchase of its equity shares by FIIs/RFPIs.

APSEZs consolidated net profit rose 30.8% to Rs 835.71 crore on 6.34% growth in net sales to Rs 1817.23 crore in Q1 June 2016 over Q1 June 2015.

APSEZ, a part of the Adani Group, is Indias largest private port operator.

Powered by Capital Market - Live News

Mahindra Holidays gains after acquisition
Oct 03,2016

The announcement was made on Saturday, 1 October 2016.

Meanwhile, the BSE Sensex was up 287.92 points, or 1.03%, to 28,153.88.

On BSE, so far 1,167 shares were traded in the counter, compared with average daily volume of 7,404 shares in the past one quarter. The stock hit a high of Rs 467 and a low of Rs 452 so far during the day. The stock hit a 52-week high of Rs 513.30 on 26 August 2016. The stock hit a 52-week low of Rs 303.75 on 5 October 2015. The stock had underperformed the market over the past 30 days till 30 September 2016, falling 6.01% compared with 1.96% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 8.64% as against Sensexs 2.66% rise.

The mid-cap company has equity capital of Rs 88.78 crore. Face value per share is Rs 10.

Nreach Online Services owns a brand GIFTXOXO, which offers over 4,000 categories of experiences and activities including travel and adventure, gourmet, health and wellness, art and learning.

Mahindra Holidays & Resorts India said this is strategic investment by the company. Nreach will help in curating experiences for the companys 2 lakh vacation ownership (Club Mahindra Holidays) members in and around various cities in India.

Net profit of Mahindra Holidays & Resorts India rose 20% to Rs 30.24 crore on 4.5% rise in net sales to Rs 228.88 crore in Q1 June 2016 over Q1 June 2015.

Mahindra Holidays & Resorts India is a part of the leisure and hospitality sector of the Mahindra Group.

Powered by Capital Market - Live News

M&M moves higher after robust tractor sales
Oct 03,2016

The company announced the monthly sales volume data during market hours today, 3 October 2016.

Meanwhile, the S&P BSE Sensex was up 323.63 points or 1.16% at 28,189.59.

On BSE, so far 62,000 shares were traded in the counter as against average daily volume of 72,528 shares in the past one quarter. The stock hit a high of Rs 1,450.50 and a low of Rs 1,402 so far during the day. The stock had hit a record high of Rs 1,508.80 on 9 August 2016. The stock had hit a 52-week low of Rs 1,092 on 12 February 2016. The stock had underperformed the market over the past one month till 30 September 2016, sliding 2.13% compared with 1.68% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 1.61% as against Sensexs 3.21% rise.

The large-cap company has equity capital of Rs 310.55 crore. Face value per share is Rs 5.

Mahindra & Mahindras (M&M) domestic tractor sales rose 70% to 29,035 units in September 2016 over September 2015. Exports rose 48% to 1,527 units in September 2016 over September 2015.

Separately, M&M announced on Saturday, 1 October 2016 that its auto sales rose 8% to 46,130 units in September 2016 over September 2015. Domestic sales rose 7.18% to 42,545 units in September 2016 over September 2015. Exports increased by 14% to 3,585 units in September 2016 over September 2015.

M&Ms net profit rose 12.4% to Rs 955.21 crore on 12.3% growth in net sales to Rs 10898.08 crore in Q1 June 2016 over Q1 June 2015.

M&M enjoys a leadership position in tractors and utility vehicles in India.

Powered by Capital Market - Live News

Ashok Leyland shrugs off weak sales data
Oct 03,2016

Meanwhile, the S&P BSE Sensex was up 288.53 points or 1.04% at 28,154.49.

On BSE, so far 6.55 lakh shares were traded in the counter as against average daily volume of 15.18 lakh shares in the past one quarter. The stock was volatile. The stock rose as much as 2.26% at the days high of Rs 81.40 so far during the day. The stock lost as much as 1.38% at the days low of Rs 78.50 so far during the day. The stock had hit a record high of Rs 112.80 on 13 April 2016. The stock had hit a 52-week low of Rs 75.15 on 30 September 2016. The stock had underperformed the market over the past one month till 30 September 2016, sliding 9.95% compared with 1.68% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 19.27% as against Sensexs 3.21% rise.

The large-cap company has equity capital of Rs 284.59 crore. Face value per share is Rs 1.

Ashok Leyland announced on Saturday, 1 October 2016 that its total sales declined 18% to 12,057 units in September 2016 over September 2015. Sales of medium & heavy commercial vehicles (M&HCV) declined 26% to 8,963 units in September 2016 over September 2015. Light commercial vehicles (LCV) sales rose 17% to 3,094 units in September 2016 over September 2015.

Ashok Leylands net profit jumped 101.2% to Rs 290.78 crore on 10.6% growth in net sales to Rs 4175.79 crore in Q1 June 2016 over Q1 June 2015.

Ashok Leyland is one of the leading manufacturers of medium and heavy commercial vehicles in India.

Powered by Capital Market - Live News

Ashok Leyland shruggs off weak sales data
Oct 03,2016

Meanwhile, the S&P BSE Sensex was up 288.53 points or 1.04% at 28,154.49.

On BSE, so far 6.55 lakh shares were traded in the counter as against average daily volume of 15.18 lakh shares in the past one quarter. The stock was volatile. The stock rose as much as 2.26% at the days high of Rs 81.40 so far during the day. The stock lost as much as 1.38% at the days low of Rs 78.50 so far during the day. The stock had hit a record high of Rs 112.80 on 13 April 2016. The stock had hit a 52-week low of Rs 75.15 on 30 September 2016. The stock had underperformed the market over the past one month till 30 September 2016, sliding 9.95% compared with 1.68% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 19.27% as against Sensexs 3.21% rise.

The large-cap company has equity capital of Rs 284.59 crore. Face value per share is Rs 1.

Ashok Leyland announced on Saturday, 1 October 2016 that its total sales declined 18% to 12,057 units in September 2016 over September 2015. Sales of medium & heavy commercial vehicles (M&HCV) declined 26% to 8,963 units in September 2016 over September 2015. Light commercial vehicles (LCV) sales rose 17% to 3,094 units in September 2016 over September 2015.

Ashok Leylands net profit jumped 101.2% to Rs 290.78 crore on 10.6% growth in net sales to Rs 4175.79 crore in Q1 June 2016 over Q1 June 2015.

Ashok Leyland is one of the leading manufacturers of medium and heavy commercial vehicles in India.

Powered by Capital Market - Live News

Indian Hume Pipe Company gains after board approves monetising Pune land
Oct 03,2016

The announcement was made on Saturday, 1 October 2016.

Meanwhile, the BSE Sensex was up 296.87 points, or 1.07%, to 28,162.83.

On BSE, so far 3,020 shares were traded in the counter, compared with average daily volume of 9,442 shares in the past one quarter. The stock hit a high of Rs 691.35 and a low of Rs 663.90 so far during the day. The stock hit a record high of Rs 699 on 29 September 2016. The stock hit a 52-week low of Rs 272.50 on 29 February 2016. The stock had outperformed the market over the past 30 days till 30 September 2016, rising 6.53% compared with 1.96% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 87.69% as against Sensexs 2.66% rise.

The small-cap company has equity capital of Rs 4.84 crore. Face value per share is Rs 2.

Indian Hume Pipe Company said it has its erstwhile pipe manufacturing factory on land admeasuring about 14.77 acres at Vadgaon in Pune, Maharashtra was closed with effect from 1 November 2015. The companys said that its board approved to explore the possibility of monetising the land and appoint reputed property consultant for identifying a developer.

Indian Hume Pipe Companys net profit jumped 311.15% to Rs 26 crore on 110.7% rise in net sales to Rs 447.07 crore in Q1 June 2016 over Q1 June 2015.

Indian Hume Pipe Company is engaged in the business of providing integrated water supply schemes including manufacturing, laying and jointing of pipelines of various pipe materials which provide infrastructure facility for development of water supply and irrigation projects.

Powered by Capital Market - Live News

Jubilant Life Sciences jumps after USFDA approval for Ruby-Fill
Oct 03,2016

The announcement was made before trading hours today, 3 October 2016.

Meanwhile, the BSE Sensex was up 253.85 points, or 0.91%, to 28,119.81.

On BSE, so far 2.42 lakh shares were traded in the counter, compared with average daily volume of 2.53 lakh shares in the past one quarter. The stock hit a high of Rs 676.10 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 652.10 so far during the day. The stock hit a 52-week low of Rs 272.50 on 20 January 2016. The stock had outperformed the market over the past 30 days till 30 September 2016, rising 12.77% compared with 1.96% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 93.26% as against Sensexs 2.66% rise.

The mid-cap pharmaceuticals and life sciences company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

Jubilant Life Sciences announced that its wholly-owned subsidiary Jubilant Pharma, through one of its units Jubilant DraxImage Inc. Montreal Canada, has received US Food and Drug Administration (USFDA) approval for RUBY-FILL, for its New Drug Application (NDA) pursuant to section 505 (b)(2) filing. This approved new drug application provides for the use of RUBY-FILL for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

The product is expected to be launched in the current quarter (third quarter of financial year 2017) under the companys registered brand name RUBY-FILL for which the current estimated US market size is $76 million and has a potential to grow up to $250 million annually in the nextfive years.

Jubilant Life Sciences consolidated net profit rose 22.49% to Rs 161.60 crore on 1.72% decline in net sales to Rs 1400.97 crore in Q1 June 2016 over Q1 June 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and drug discovery solutions. The companys strength lies in its unique offerings of pharmaceuticals and life sciences products and services across the value chain.

Powered by Capital Market - Live News

Eicher Motors moves north after strong monthly sales
Oct 03,2016

The company announced the monthly sales volume data on Saturday, 1 October 2016.

Meanwhile, the S&P BSE Sensex was up 258.68 points or 0.93% at 28,124.64.

On BSE, so far 1,542 shares were traded in the counter as against average daily volume of 4,084 shares in the past one quarter. The stock hit a high of Rs 25,873.70 and a low of Rs 25,125 so far during the day. The stock had hit a record high of Rs 26,601.95 on 29 September 2016. The stock had hit a 52-week low of Rs 14,817.75 on 19 January 2016. The stock had outperformed the market over the past one month till 30 September 2016, advancing 8.13% compared with 1.68% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 29.62% as against Sensexs 3.21% rise.

The large-cap company has equity capital of Rs 27.20 crore. Face value per share is Rs 10.

Eicher Motors motorcycle division exports rose 18% to 884 units in September 2016 over September 2015.

Separately, Eicher Motors announced on Saturday, 1 October 2016 that VE Commercial Vehicles (VECV) reported a 14% increase in total sales at 4,843 units in September 2016 over September 2015.

On a consolidated basis, Eicher Motors net profit surged 58.61% to Rs 376.29 crore on 42.04% growth in net sales to Rs 1549.74 crore in the quarter ended 30 June 2016 over the quarter ended 30 June 2015.

Eicher Motors (EML) is the flagship company of the Eicher Group. EML is one of the leading players in the Indian automotive space. EML owns the iconic Royal Enfield motorcycle business which leads the premium motorcycle segment in India. EMLs joint venture with the Volvo group, VE Commercial Vehicles, designs, manufactures and markets reliable, fuel-efficient trucks and buses.

Powered by Capital Market - Live News

Maruti Suzuki jumps after good September sales
Oct 03,2016

The announcement was made on Saturday, 1 October 2016.

Meanwhile, the BSE Sensex was up 103.49 points, or 0.37%, to 27,969.45.

On BSE, so far 14,000 shares were traded in the counter, compared with average daily volume of 71,985 shares in the past one quarter. The stock hit a high of Rs 5,695 so far during the day, which is also record high for the counter. The stock hit a low of Rs 5,628 so far during the day. The stock hit a 52-week low of Rs 3,202.10 on 29 February 2016. The stock had outperformed the market over the past 30 days till 30 September 2016, rising 8.32% compared with 1.96% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 31.53% as against Sensexs 2.66% rise.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

Maruti Suzuki India (MSIL)s domestic sales surged 29.4% to 1.37 lakh units in September 2016 over September 2015. Exports jumped 54% to 11,822 units in September 2016 over September 2015.

Maruti Suzuki Indias net profit rose 23% to Rs 1486.20 crore on 12.1% rise in net sales to Rs 14654.50 crore in Q1 June 2016 over Q1 June 2015.

Maruti is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation currently holds 56.21% stake in Maruti (as per the shareholding pattern as on 30 June 2016).

Powered by Capital Market - Live News

Tata Motors gains after reporting decent growth in September sales
Oct 03,2016

The company announced the monthly sales volume data on Saturday, 1 October 2016.

Meanwhile, the S&P BSE Sensex was up 98.33 points or 0.35% at 27,964.29.

On BSE, so far 41,000 shares were traded in the counter as against average daily volume of 8.70 lakh shares in the past one quarter. The stock hit a high of Rs 544.95 and a low of Rs 539.65 so far during the day. The stock had hit a 52-week high of Rs 598.60 on 7 September 2016. The stock had hit a 52-week low of Rs 266 on 11 February 2016. The stock had outperformed the market over the past one month till 30 September 2016, advancing 1.22% compared with 1.68% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 16.44% as against Sensexs 3.21% rise.

The large-cap company has equity capital of Rs 577.44 crore. Face value per share is Rs 2.

The companys domestic sales of Tata commercial and passenger vehicles rose 5% to 42,961 units in September 2016 over September 2015. Exports surged 29% to 5,687 units in September 2016 over September 2015.

Tata Motors consolidated net profit declined 57% to Rs 2260.40 crore on 10.1% rise in net sales to Rs 64940.12 crore in Q1 June 2016 over Q1 June 2015.

Tata Motors is a market leader in commercial vehicles in India. The companys British unit Jaguar Land Rover (JLR) sells premium luxury cars.

Powered by Capital Market - Live News

Jubilant Life Sciences jumps after subsidiary raises funds
Sep 30,2016

The announcement was made after market hours yesterday, 29 September 2016.

Meanwhile, the BSE Sensex was up 50.52 points, or 0.18%, to 27,878.05.

On BSE, so far 1.35 lakh shares were traded in the counter, compared with average daily volume of 2.51 lakh shares in the past one quarter. The stock hit a high of Rs 619.70 and a low of Rs 589.10 so far during the day. The stock hit a record high of Rs 655 on 27 September 2016. The stock hit a 52-week low of Rs 272.50 on 20 January 2016. The stock had outperformed the market over the past 30 days till 29 September 2016, rising 9.81% compared with 2.20% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 85.46% as against Sensexs 2.51% rise.

The mid-cap company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

Jubilant Life Sciences said that its wholly-owned subsidiary, Jubilant Pharma (JPL), has successfully completed the pricing of its rated unsecured high yield bonds (the notes) at a yield of 4.875% per annum, issued at par for $300 million and maturing in September 2021. The issuer (JPL) has been rated BB- by Standard & Poors Ratings Services (S&P) and Fitch Inc. (Fitch) and the issue (the notes) has been rated BB- by S&P and BB by Fitch.

The net proceeds of the notes shall be used to prepay the existing debts of JPL and its subsidiaries; for upstreaming upto $50 million to Jubilant Life Sciences for prepayment of its existing debts; and for general corporate purposes, the company said in a statement.

Jubilant Life Sciences consolidated net profit rose 22.49% to Rs 161.60 crore on 1.72% decline in net sales to Rs 1400.97 crore in Q1 June 2016 over Q1 June 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and drug discovery solutions. The companys strength lies in its unique offerings of pharmaceuticals and life sciences products and services across the value chain.

Powered by Capital Market - Live News

Liquor stocks in demand
Sep 30,2016

Empee Distilleries (up 14.58%), Tilaknagar Industries (up 7.83%), G M Breweries (up 7.01%), Radico Khaitan (up 6.61%), United Spirits (up 6.17%), Pioneer Distilleries (up 5.95%), Associated Alcohols & Breweries (up 4.42%) and United Breweries (up 3.25%), edged higher. Khoday India was down 4.41%.

The S&P BSE Sensex was up 72.94 points, or 0.26% at 27,900.47.

According to reports, Bharatiya Janata Party (BJP) leader Ashwani Upadhaya had sought a complete ban on liquor across the nation. The Public Interest Litigation (PIL) filed by Upadhyay said the use of alcohol should be restricted to medical purposes and sale of liquor and intoxicating drinks and drugs must be prohibited completely or allowed with strict conditions. In his petition, Upadhyay also said that liquor is the root cause of most road accidents, road rages, crime against women, domestic violence, rape and murder and many other social evils, reports added.

However, a division bench of the Supreme Court, headed by Justice Arjan Kumar Sikri and also comprising Justice N. V. Ramanna, after finding no merit in his plea, dismissed it.

Meanwhile, the Patna High Court today, 30 September 2016, reportedly struck down Bihar governments controversial Prohibition of Liquor Act, terming it illegal. In April 2016, the Nitish Kumar government had imposed total prohibition on liquor in the state.

The Bihar Hotels and Bars Association had filed a petition before the High Court asking it to scrap the ban. Soon after the Bihar Excise (Amendment) Act, 2016 was passed in March, total prohibition was imposed in Bihar because of which consumption and selling of liquor in the state had become illegal, media reports suggested.

Powered by Capital Market - Live News

Volumes jump at CRISIL counter
Sep 30,2016

CRISIL clocked volume of 30,000 shares by 13:47 IST on BSE, a 32.11-times surge over two-week average daily volume of 1,000 shares. The stock shed 0.09% to Rs 2,173.45.

Tata Chemicals notched up volume of 12.16 lakh shares, a 19.38-fold surge over two-week average daily volume of 63,000 shares. The stock rose 2.64% to Rs 522.8

Havells India saw volume of 9.02 lakh shares, a 11.63-fold surge over two-week average daily volume of 78,000 shares. The stock rose 2.3% to Rs 418.

Grasim Industries clocked volume of 63,000 shares, a 8.52-fold surge over two-week average daily volume of 7,000 shares. The stock rose 2.44% to Rs 4,810.50

Berger Paints India saw volume of 2.61 lakh shares, a 7.41-fold rise over two-week average daily volume of 35,000 shares. The stock rose 1.54% to Rs 260.95.

Powered by Capital Market - Live News

Cipla slips after USFDA issues observations to Goa units
Sep 30,2016

The announcement was made during trading hours today, 30 September 2016.

Meanwhile, the BSE Sensex was down 24.41 points, or 0.09%, to 27,803.12.

The counter witnessed high volumes. On BSE, so far 7.67 lakh shares were traded in the counter, compared with average daily volume of 1.88 lakh shares in the past one quarter. The stock hit a high of Rs 605 and a low of Rs 562.05 so far during the day. The stock hit a 52-week high of Rs 704.75 on 29 October 2015. The stock hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past 30 days till 29 September 2016, rising 4.94% compared with 2.20% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 18.31% as against Sensexs 2.51% rise.

The large-cap company has equity capital of Rs 160.84 crore. Face value per share is Rs 2.

Cipla said that United States Food and Drug Administration (USFDA) recently concluded audit of the companys three manufacturing facilities at Goa and issued 4 observations across these three facilities. These observations were primarily procedural in nature and the company has already responded to these observations. Cipla said it continues to operate its facilities with a high level of compliance and control.

On a consolidated basis, Cipla reported 43.74% fall in net profit to Rs 365.24 crore on 6.94% fall in net sales to Rs 3499.81 crore in Q1 June 2016 over Q1 June 2015.

Cipla is a global pharmaceutical company.

Powered by Capital Market - Live News

Firstsource Solutions gains after subsidiary repays debt
Sep 30,2016

The announcement was made during trading hours today, 30 September 2016.

Meanwhile, the BSE Sensex was down 80.64 points, or 0.29%, to 27,746.89.

On BSE, so far 2.35 lakh shares were traded in the counter, compared with average daily volume of 6.70 lakh shares in the past one quarter. The stock hit a high of Rs 41 and a low of Rs 39 so far during the day. The stock hit a 52-week high of Rs 53.65 on 26 July 2016. The stock hit a 52-week low of Rs 26.30 on 1 October 2015. The stock had underperformed the market over the past 30 days till 29 September 2016, falling 10.84% compared with 2.20% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 16.29% as against Sensexs 2.51% rise.

The small-cap company has equity capital of Rs 675.65 crore. Face value per share is Rs 10.

Firstsource Solutions said that Firstsource Group USA, Inc, a wholly-owned subsidiary of the company, has successfully made its sixth quarterly repayment of $11.25 million on its outstanding debt on 30 September 2016.

With this, the companys subsidiary repaid $67.50 million of debt so far since 30 June 2015.

On 27 May 2015, the company announced that it was successful in refinancing the long term and short term loans of its subsidiaries on better commercial terms maintaining the same repayment schedule for the balance principal outstanding on the long term loans.

On a consolidated basis, Firstsource Solutions net profit fell 3.73% to Rs 73.36 crore on 2.67% increase in net sales to Rs 875.25 crore in Q1 June 2016 over Q4 March 2016.

Firstsource Solutions is a global provider of customised BPM (Business Process Management). It operates in India, the Philippines, Sri Lanka, the UK and the US.

Powered by Capital Market - Live News